J.Safra Asset Management Corp

Position in MRK — Merck & Co., Inc.

CIK 1535293 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$552,293

+$53,812 QoQ

Shares Held

4,298

+3.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#2,614

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J.Safra Asset Management Corp holds $13,218,561 across 10 Drug Manufacturers - General names. MRK ranks #6 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,918	$8,297,657
2	ABBV	AbbVie Inc.	5,519	$1,388,801
3	AMGN	Amgen Inc	3,204	$1,160,232
4	JNJ	Johnson & Johnson	4,182	$1,062,102
5	AZN	Astrazeneca PLC	3,599	$682,442
6	MRK	Merck & Co., Inc. This page	4,298	$552,293
7	GILD	Gilead Sciences, Inc.	275	$34,743
8	NVO	Novo Nordisk A S	428	$20,518

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$552,293	4,298	+3.7%	Shares	Sole	2026-08-06
2026-03-31	$498,481	4,144	+725.5%	Shares	Sole	2026-05-04
2025-12-31	$52,840	502	+11.6%	Shares	Sole	2026-02-11
2025-09-30	$37,768	450	+53.6%	Shares	Sole	2025-10-29
2025-06-30	$23,193	293	-93.1%	Shares	Sole	2025-10-29
2025-03-31	$382,557	4,262	+44.4%	Shares	Sole	2025-10-29
2024-12-31	$293,664	2,952	+137.5%	Shares	Sole	2025-02-06
2024-09-30	$141,155	1,243	+31.5%	Shares	Sole	2024-11-13
2024-06-30	$116,991	945	+107.2%	Shares	Sole	2024-07-17
2024-03-31	$60,169	456	-71.2%	Shares	Sole	2024-05-09
2023-12-31	$172,578	1,583	-19.3%	Shares	Sole	2024-02-02
2023-09-30	$201,884	1,961	0.0%	Shares	Sole	2023-11-13
2023-06-30	$226,279	1,961	0.0%	Shares	Sole	2023-08-04
2023-03-31	$208,630	1,961	0.0%	Shares	Sole	2023-05-12
2022-12-31	$217,572	1,961	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.